Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
S&P Biotech SPDR
(NY:
XBI
)
101.51
+1.37 (+1.37%)
Official Closing Price
Updated: 8:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about S&P Biotech SPDR
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
The June Job Report Could Push Rates Sharply Higher
July 01, 2023
This week's June job report could cause rates, the dollar, and even oil to all rise sharply.
Via
Talk Markets
Biotech And Healthcare Stocks Lagging
June 21, 2023
Healthcare is a laggard with XLV down YTD but UNH is still a core position.
Via
Talk Markets
“The One That Got Away” Stock Market (And Sentiment Results)
June 08, 2023
It was very lonely being a bull last fall when the S&P 500 was in the 3600s to 3700s. The good news is there’s plenty of runway ahead. The bad news is, it’s going to be a bit more tricky.
Via
Talk Markets
Market Mixes It Up With A Broad Rally
June 05, 2023
Biotech stocks remain sluggish but the longer-term outlook for breakthrough therapies - gene therapy, obesity, CNS, RNA - remain positive.
Via
Talk Markets
“Skip Or Flip” Stock Market (And Sentiment Results)
June 01, 2023
We are at the cusp of a sea change, and the knock-on effects will be material. We expect to see two meaningful changes in the coming months as a result of the Fed being done.
Via
Talk Markets
A Good Week For The Market But A Pause In The Biotech Rally
May 22, 2023
Healthcare stocks have been lagging in 2023 with the XLV down 1.97% MTD and 3.34% YTD with CVS and UNH contributing to the weakness.
Via
Talk Markets
The Dierks Bentley “Feels Like Gold” Stock Market (And Sentiment Results)
May 18, 2023
Markets top when everyone is overweight stocks on margin. We are nowhere close to that point
Via
Talk Markets
Why These 3 Nasdaq Stocks Buckled Today
May 16, 2023
The FTC's decision to sue to block a high-profile merger is weighing on biotech valuations today.
Via
The Motley Fool
Time To Play Small Cap Life Science Stocks
May 15, 2023
The overall market sentiment has been hit hard by MACRO concerns. The dominating narrative is the Fed and the Debt Ceiling.
Via
Talk Markets
Biotech ETFs Pop On M&A Resurgence
May 10, 2023
The biopharma industry has seen a recent upswing in mergers and acquisitions (M&A).
Via
Talk Markets
Something Happened In Biotech Last Week
May 08, 2023
Biotech stocks were more constructive last week with some sharp moves up.
Via
Talk Markets
Small & Mid Cap Life Science Stock Portfolio: Some Good Picks In A Stalled Sector
May 01, 2023
A pivotal week looks to be shaping up with the usual macro concerns arising, such as a Fed meeting and big earnings waiting just around the corner. One possible path to help navigate around these macro...
Via
Talk Markets
Second Quarter Outlook For Biotech Stocks
April 25, 2023
Biotech stocks have been consolidating recently but may be ready to rally higher due to factors such as a declining 10-year yield and growing M&A activity.
Via
Talk Markets
“Knockin’ On Heaven’s Door” Stock Market (And Sentiment Results)
April 20, 2023
We’ve come through the “point of control” on the S&P 500. This simply means there is less “overhead supply” to come on the market as we press higher.
Via
Talk Markets
Where Is The Current Bull Market? Scan Of Stocks Gaining Over 20% Over The Past Week Almost Exclusively Yields Biotech Names
April 20, 2023
Where is the current bull market? All indications would be that it's in biotech! The broader market is not really moving. There have been plenty of attention-grabbing headlines, and earnings season is...
Via
Benzinga
Thermo Fisher, Principal Financial Group, And Two Promising ETFs Steal The Show On CNBC's 'Final Trades'
April 14, 2023
On CNBC’s "Halftime Report Final Trades," Bryn Talkington of Requisite Capital Management named SPDR S&P Biotech ETF (NYSE: XBI), which is trading in a tight range <
Via
Benzinga
Mifepristone Abortion Pill Access in Limbo: Justice Department May Ask Supreme Court's Intervention
April 13, 2023
U.S. Attorney General Merrick Garland said that the Justice Department would file an appeal with the U.S. Supreme Court seeking to block the entirety of Kacsmaryk's order suspending the FDA approval of...
Via
Benzinga
Women's Reproductive Rights: US Court Preserves Access To Abortion Pill For Now, But With Tighter Rules
April 13, 2023
A U.S. federal appeals court has temporarily blocked a decision by a Texas judge to halt the FDA's approval of a widely used abortion drug.
Via
Benzinga
New York and California Prepare For Potential Mifepristone Ban In Texas With Stockpiling Of Alternative Abortion Medications
April 12, 2023
New York and California are stockpiling an alternative abortion medication in case a Texas judge's order suspending the FDA approval of the primary drug, mifepristone, goes into effect later this...
Via
Benzinga
Attorney Generals of Over 20 States Sound Alarm Over Suspension Of Abortion Med Approval: "Devastating Risks" Ahead
April 11, 2023
In a new court filing, the Democratic attorneys general for 23 U.S. states have reportedly warned that a federal judge's decision to suspend the FDA's approval of mifepristone "presents devastating...
Via
Benzinga
Time to Spring-Clean...Your Stock Portfolio
April 10, 2023
Plus, Howard Marks, co-founder of Oaktree Capital Management, joins the podcast to discuss topics including China's effect on inflation in the U.S.
Via
The Motley Fool
April Is Busting Out For Healthcare And Biotech
April 10, 2023
Last week was a good week for healthcare stocks and most large cap biopharmaceutical stocks resumed an upward trend.
Via
Talk Markets
FDA Withdraws Lone Premature Birth Drug Makena Over Lack of Proven Benefits
April 06, 2023
Via
Benzinga
Large Cap Biopharmaceuticals Q1 2023: In This Bullish Run Biotech Lags
April 03, 2023
It was very difficult to make money in Q1 trading healthcare or biotech ETFs because of the sharp rally in other sectors. Nonetheless, there were two big winners.
Via
Talk Markets
The Stock Market Rally May Fizzle The Week Of April 3
April 02, 2023
I think what we’ve seen over the last week or two has been driven by systematic trading and rebalancing of portfolios, as investors have sold financials and moved into mega-cap technology names. But...
Via
Talk Markets
Biotech And Life Science Trades: Q1 2023 Performance By The Numbers
April 01, 2023
Despite a strong month and a great finish to the quarter, many traders remain cautious about the market. It’s been a volatile time after the collapse of Silicon Valley Bank, but the first quarter of...
Via
Talk Markets
“Don’t Stop Believin'” Stock Market (And Sentiment Results)
March 30, 2023
In this week’s AAII Sentiment Survey result, bullish percent ticked up to 22.5% from 20.9% the previous week.
Via
Talk Markets
This Blue Chip Dividend Stock Should Return to Form When the Risk Premium Flips
March 30, 2023
T-bills may be the flavor of the month, but history has shown this top biotech stock is a far better long-term investment.
Via
The Motley Fool
The 3 Best Growth Stocks to Buy in the Biotech Sector
March 29, 2023
These three biotech growth stocks are brimming with potential and could offer massive upside for patient investors.
Via
InvestorPlace
Can Healthcare Stocks Survive Macro Headwinds?
March 27, 2023
Healthcare stocks are supposed to be defensive plays in a choppy market. However, over the past 18 months, the XLV is flat and down 6% over one year.
Via
Talk Markets
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.